drugset / Trial / NCT06056583
Drug Excretion in Breast Milk
Phase 4
Recruiting
50 enrolled
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collab
NaSequentialOpen-labelBasic science
Summary
This is a prospective, non-randomized, phase I study design evaluating the in vivo activities and expression of OCT1 and BCRP in mammary gland of lactating women at three time points postpartum.
Timeline
- Start
- 2023-12-04
- Primary completion
- 2028-09-30
- Completion
- 2028-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cimetidine | Small molecule | 200 mg | Oral |